0001801385-22-000005.txt : 20220301
0001801385-22-000005.hdr.sgml : 20220301
20220301212529
ACCESSION NUMBER: 0001801385-22-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220226
FILED AS OF DATE: 20220301
DATE AS OF CHANGE: 20220301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Romano Kathryn
CENTRAL INDEX KEY: 0001801385
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38210
FILM NUMBER: 22701036
MAIL ADDRESS:
STREET 1: C/O KRYSTAL BIOTECH, INC.
STREET 2: 2100 WHARTON STREET, SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Krystal Biotech, Inc.
CENTRAL INDEX KEY: 0001711279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 821080209
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: (412) 586-5830
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
4
1
wf-form4_164618791185342.xml
FORM 4
X0306
4
2022-02-26
0
0001711279
Krystal Biotech, Inc.
KRYS
0001801385
Romano Kathryn
C/O KRYSTAL BIOTECH, INC.
2100 WHARTON STREET, SUITE 701
PITTSBURGH
PA
15203
0
1
0
0
Chief Accounting Officer
Common Stock
2022-02-26
4
F
0
1472
62.50
D
18128
D
Stock Option (Right to Buy)
63.55
2022-02-28
4
A
0
50000
0
A
2032-02-28
Common Stock
50000.0
50000
D
Represents tax withholding upon the vesting of 4,900 shares of restricted stock on February 26, 2022.
The closing price on February 25, 2022 of the Company's common stock on NASDAQ.
The option vests in four equal annual installments beginning on February 28, 2023.
/s/ Kathryn Romano
2022-03-01